MinHwa Shin

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursInnate immunitySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 08, 2024
Current Developments in NK Cell Engagers for Cancer Immunotherapy: Focus on CD16A and NKp46.

Min Hwa Shin, Eunha Oh, Dohsik Minn

|Jun 28, 2023
Recent Advances in CAR-Based Solid Tumor Immunotherapy.

Min Hwa Shin, Eunha Oh, Yunjeong Kim

|Apr 30, 2021
Hypoxia-Driven HIF-1α Activation Reprograms Pre-Activated NK Cells towards Highly Potent Effector Phenotypes via ERK/STAT3 Pathways.

Seon Ah Lim, Yunwon Moon, Min Hwa Shin

|May 13, 2020
NK Cell-Based Immunotherapies in Cancer.

Min Hwa Shin, Junghee Kim, Siyoung A Lim

|Apr 09, 2020
Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade.

Min Hwa Shin, Jiyoung Kim, Siyoung A Lim

|Mar 30, 2019
T cell stemness and dysfunction in tumors are triggered by a common mechanism.

Suman Kumar Vodnala, Robert Eil, Rigel J Kishton

Pageof 1

Frequent Collaborators

3 joint publications

Kyung-Mi Lee

2 joint publications

Dohsik Minn

1 joint publications

Junghee Kim

1 joint publications

Siyoung A Lim